Alzheimer's Drug Review Ignites Backlash From Experts

(MedPage Today) -- A systematic review suggested that drugs targeting amyloid beta appeared to have no clinically meaningful positive effects, sparking swift backlash from Alzheimer's disease experts. The review assessed 17 trials conducted between...
Source
MedPage Today
Opens original article in a new tab



